98%
921
2 minutes
20
Background: Numerous national health intervention campaigns, e.g. supplementary immunization campaigns/activities (SIAs), have been conducted in low- and middle-income countries (LMIC) in the last decades. These campaigns are rarely evaluated for overall health outcomes. Information on campaigns is critical for evaluations. We investigated; 1) quality of campaign information sources and 2) implication of quality for outcome evaluations.
Methods: We focused on three campaign types: oral polio vaccine (OPV), vitamin A supplementation (VAS) and measles vaccine (MV) campaigns in two case countries, for which "gold standard" information on campaigns collected regularly at Health and Demographic Surveillance Systems (HDSS) sites: Guinea-Bissau and Bangladesh. We compared the campaign information from HDSS with information from the World Health Organisation (WHO) and the Rotary Foundation (Rotary, only OPV campaigns). First, campaigns were matched and compared based on intervention type, date of campaign and target age group. Second, we assessed the implications of using various sources of campaign information on the estimated effect of OPV campaigns on all-cause under-3-year mortality in Cox proportional hazards regression models.
Results: The proportion of matched OPV campaigns was highest between HDSS and Rotary. VAS campaigns (only information from HDSS and WHO) matched poorly. The estimated effect of OPV campaigns information on child mortality in Bangladesh went from being statistically significant (HR = 0.69 (0.52-0.90)) using HDSS campaign information to not being significant (HR = 0.93 (0.71-1.21) using WHO campaign information.
Conclusion: Compared with the HDSS, Rotary had the best campaign information on the conduct of OPV campaigns, whereas the WHO quality of campaign information was low for both OPV and VAS. A low quality of campaign information may alter conclusions of health outcome evaluations. Reliable and precise information on campaigns is essential to assess their effects. Public and private campaign stakeholders should track campaign information meticulously and support that publicly data is available for researchers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616566 | PMC |
http://dx.doi.org/10.1016/j.jvacx.2024.100588 | DOI Listing |
Rev Esp Salud Publica
June 2025
Societat Catalana de Pediatria, Asociación Española de Vacunología. Barcelona. España.
The history of poliomyelitis (polio) vaccination is both complex and fascinating. This article focuses on two distinct, but related, aspects of this history: the discovery and development of the original polio vaccines in the U.S.
View Article and Find Full Text PDFFront Public Health
July 2025
Beijing Institute of Biological Products, Co., Ltd., Beijing, China.
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%. However, challenges persist, including endemic transmission in conflict zones, the emergence of vaccine-derived polioviruses (VDPVs), and the complex logistics of vaccine production and distribution.
View Article and Find Full Text PDFVaccines (Basel)
June 2025
Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Background: Poliomyelitis is a vaccine-preventable disease, with oral poliomyelitis vaccines (OPVs) and injectable poliomyelitis vaccines. In the Democratic Republic of the Congo (DRC), circulating vaccine-derived polioviruses (VDPVs) persist due to intrinsic and extrinsic factors, including the quality of the cold chain, which may make the vaccines less effective. This study's objective was to evaluate the cold chain's quality of OPVs and its effect on the vaccine's viability and potency at different levels in health systems in Kinshasa.
View Article and Find Full Text PDFACS EST Air
July 2025
Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
In this study, the acellular dithiothreitol (DTT) assay, the cellular DCFH-DA assay on human lung epithelial cells, and gene expression measurements were used to assess the toxicity of water-soluble (WS) PM relating to reactive oxygen species (ROS) in summer at an Eastern Mediterranean urban site. Large influences from anthropogenic sources on health risks were observed with acellular and cellular assays. Anthropogenic biomass burning (BB) and natural dust events increased human pulmonary exposure to the oxidative potential (OP) of WS-PM by 209 and 47%, respectively, compared to regular periods.
View Article and Find Full Text PDFBMC Public Health
April 2025
Sydani Group, Abuja, Nigeria.
Background: Integrating Routine Immunization (RI) into COVID-19 vaccination implies that COVID-19 vaccination is the primary focus, with RI services added to the effort. During COVID-19 vaccination campaigns in Nigeria, healthcare workers also provided routine vaccines such as measles and polio to individuals who came for their COVID-19 shots. This paper aims to demonstrate that integrating RI into COVID-19 vaccination increases overall vaccine coverage but may introduce equity issues.
View Article and Find Full Text PDF